Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-02 Sale |
2020-11-03 4:01 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $31.09 | $18,654 | 27,725 (Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 5:56 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $35 | $87,500 | 834,023 (Indirect Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 5:31 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $34.46 | $172,300 | 1,317,490 (Indirect Direct) |
View |
| 2020-10-07 Sale |
2020-10-09 4:48 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
7,500 | $35 | $262,500 | 836,523 (Indirect Direct) |
View |
| 2020-10-07 Sale |
2020-10-09 4:45 pm |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
12,000 | $35 | $420,000 | 42,875 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
600 | $30.22 | $18,132 | 28,325 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-16 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $30.96 | $154,800 | 1,322,490 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-02 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
600 | $31.58 | $18,948 | 28,925 (Direct) |
View |
| 2020-08-20 Sale |
2020-08-21 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
3,457 | $30 | $103,710 | 1,327,490 (Indirect Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 4:45 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
1,543 | $30 | $46,290 | 1,330,947 (Indirect Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
600 | $26.28 | $15,768 | 29,525 (Direct) |
View |
| 2020-07-15 Sale |
2020-07-16 4:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $32.12 | $160,600 | 1,332,490 (Indirect Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 5:48 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
850 | $32.43 | $27,566 | 30,125 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-15 Exercise |
2020-10-16 5:56 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 834,023 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 5:56 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 834,023 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:48 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
7,500 | $2.67 | 836,523 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:48 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
7,500 | $0 | 836,523 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:45 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
12,000 | $18.98 | 42,875 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:45 pm |
N/A 2029-03-06 |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
12,000 | $0 | 42,875 (Direct) |
View |
Ownership |
2020-10-06 4:39 pm |
N/A 2030-08-16 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
0 | $0 | 125,000 (Direct) |
View |
Ownership |
2020-10-06 4:37 pm |
N/A 2030-08-31 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey See Remarks |
0 | $0 | 125,000 (Direct) |
View |